Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

SUBSEQUENT EVENTS (Narrative) (Details)

v3.24.1
SUBSEQUENT EVENTS (Narrative) (Details) - USD ($)
1 Months Ended
Apr. 15, 2024
Feb. 28, 2024
Feb. 26, 2024
Kadimastem [Member] | Loan Agreement [Member]      
Disclosure of non-adjusting events after reporting period [line items]      
Loan   $ 650,000  
Borrowings, interest rate   9.00%  
Percentage of proceeds derived from any operation sale   10.00%  
Kadimastem [Member] | Loan Agreement [Member] | First Installments [Member]      
Disclosure of non-adjusting events after reporting period [line items]      
Loan   $ 300,000  
Kadimastem [Member] | Loan Agreement [Member] | Second Installments [Member]      
Disclosure of non-adjusting events after reporting period [line items]      
Loan   $ 350,000  
Subsequent Event [Member] | Potential Reverse Merger With Kadimastem [Member]      
Disclosure of non-adjusting events after reporting period [line items]      
Proportion of ownership interests held by non-controlling interests   12.00%  
Subsequent Event [Member] | Oranim Pharm [Member]      
Disclosure of non-adjusting events after reporting period [line items]      
Borrowings, interest rate 15.00%    
Subsequent Event [Member] | Kadimastem [Member] | Potential Reverse Merger With Kadimastem [Member]      
Disclosure of non-adjusting events after reporting period [line items]      
Percentage of issued and outstanding shares held   88.00%  
Subsequent Event [Member] | Imc Holdings Ltd [Member]      
Disclosure of non-adjusting events after reporting period [line items]      
Percentage of issued and outstanding shares held     74.00%
Failure to meet remaining payments will result in transfer of IMC Holdings Ltd. shares 51.00%